MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Maintenance of safinamide 100 mg daily long-term

    N. Foncea (Galdakao, Spain)

    Objective: Evaluating the maintenance of safinamide 100 mg daily as a long-term treatment. Background: The effects of safinamide were investigated in studies 016, 018 and…
  • 2018 International Congress

    Effectiveness of an Activity-based Integrative Group Therapy (ParkEASE) on Health-Related-Quality of Life of People with Parkinson’s Disease and of their Caregivers: A Retrospective Pilot Study

    D. Tsang, R. Wong, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To evaluate the effectiveness of ParkEASE in improving health related quality of life(HRQoL) of people with Parkinson’s Disease(PD) and their caregivers. This pilot study…
  • 2018 International Congress

    Impact of a Parkinson’s Disease-Specific Order Set on Inpatient Medication Administration

    D. Larson, C. Zadikoff, M. Afshari, Y. Kianirad (Chicago, IL, USA)

    Objective: To determine the efficacy of a Parkinson’s Disease (PD)-Specific Electronic Medical Record (EMR) Order Set in reducing the rate of medication mis-administration for PD…
  • 2018 International Congress

    Personal KinetiGraph™ Movement Recording System: An Assessment of Utility in a Movement Disorder Clinic

    F. Nahab, H. Abuhussain, L. Moreno (La Jolla, CA, USA)

    Objective: The objective of this open-label study was to evaluate the clinical utility of the Personal KinetiGraph™ (PKG) Movement Recording System in the care of…
  • 2018 International Congress

    Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease

    H. Jeong, S. Chung, J. Oh, J. Kim, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the relationship between the sub-regional pattern of striatal dopamine depletion and cognitive impairment in early-stage Parkinson’s disease (PD), and determine the effect…
  • 2018 International Congress

    The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study

    A. Velon, M. Mendes, R. Almendra, A. Almeida, M. Correia, C. (Vila Real, Portugal)

    Objective: Compare cognitive function between Vascular Parkinsonism (VaP) and Parkinson´s Disease (PD) patients. Background: Portuguese version of Montreal Cognitive Assessment (MoCA) is a validated screening…
  • 2018 International Congress

    Integrated whole exome sequencing and chromosomal microarray in familial Parkinson’s disease

    L. Robak, R. Du, B. Yuan, S. Gu, Z. Akdemir, J. Jankovic, J. Lupski, J. Shulman (Houston, TX, USA)

    Objective: To determine whether whole exome sequencing (WES) plus chromosomal microarray analysis (CMA) yield a genetic etiology in a cohort of 110 individuals with familial…
  • 2018 International Congress

    Relationship between cyclooxygenase-2 gene polymorphisms and Parkinson’s disease susceptibility in Chinese Han population

    M. Ye, Y. Yao, H. Gao (Nanjing, China)

    Objective: To investigate relationship between the cyclooxygenase-2 (COX-2) gene promoter region (rs20417, rs689466, rs689465) and 3'untranslated region (rs5275) polymorphisms with Parkinson’s disease (PD) susceptibility in…
  • 2018 International Congress

    Therapeutic Drug Monitoring and Pharmacogenetic Tests as Tools in Pharmacovigilance of Anti Parkinson’s Therapy

    N. Verma (Baddi, India)

    Objective: Parkinson's disease (PD) is the second most prevalent neurodegenerative disease worldwide, affecting more than 7 million people worldwide. However, treatment outcome in many patients…
  • 2018 International Congress

    Decreased interhemispheric homotopic connectivity in Parkinson’s disease patients with freezing of gait: A resting state fMRI study

    L. Li, Y. Yuan, K. Zhang (Nanjing, China)

    Objective: Freezing of gait is a common complaint in patients with Parkinson’s disease (PD). However, the neural bases of freezing of gait in PD remain…
  • « Previous Page
  • 1
  • …
  • 253
  • 254
  • 255
  • 256
  • 257
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley